❮
❯
(Conclusion) Last week, we discussed some possible pitfalls we may have fallen into in responding to the Omicron surge, causing...
(First of two parts) Although only a total of 43 cases of Omicron have been genomically identified as of Jan....
We hope you all had a meaningful Christmas, despite the calamity which rendered thousands of our countrymen homeless, foodless, workless...
We share the optimism of Fr. Nicanor Austriaco Jr., OCTA research fellow, who reported during the President’s weekly “Talk to...
Nothing can be more frustrating for a physician than to be bluntly told by a recalcitrant smoker that “his...
On Nov. 25, the Concerned Doctors and Citizens of the Philippines (CDC PH) organized the first Philippine COVID summit to...
Remember the warning in the old “Jaws” movies: “Just when you thought it was safe to go back in the...
(Conclusion) In March, even before global scientists sounded the alarm on mass vaccination, we proposed to suspend the vaccination in...
(Conclusion) In last week’s column, we discussed that ivermectin and molnupiravir may both be considered valuable additions to our early-treatment...
(First of two parts) In the past several days, some readers have asked us about the new antiviral drug molnupiravir,...
